Letter to the editor: Comments on 'A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation'
1 Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: m.h.m.diekstra@erasmusmc.nl.
2 Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: r.malmberg@erasmusmc.nl.
3 Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: s.sleijfer@erasmusmc.nl.
4 Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: r.w.f.vanleeuwen@erasmusmc.nl.